Caris Life Sciences files for $424M IPO

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.

Jun 10, 2025 - 22:20
 0
Caris Life Sciences files for $424M IPO

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.